Critical Care Reviews Podcast COVID STEROID 2 Trial Results Presentation - Panel Discussion
Oct 26, 2021
Panelists discuss the dosing impacts of steroids in the COVID STEROID 2 trial, embracing Bayesian approaches in clinical trials for more nuanced interpretations, navigating complexities in trial interpretation beyond statistical significance, debating optimal dosage of dexamethasone in COVID-19 treatment, analyzing timing and effectiveness of corticosteroids in ARDS, and reflecting on the collaborative effort in advancing understanding of COVID-19 treatment.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Introduction
00:00 • 5min
Embracing Bayesian Approaches in Clinical Trials
05:20 • 18min
Navigating the Complexities of Trial Interpretation
23:33 • 5min
Optimal Dosage of Dexamethasone in COVID-19 Treatment
29:02 • 4min
Analysis of Timing and Effectiveness of Corticosteroids in ARDS Treatment
32:47 • 2min
Reflective Discussion on COVID STEROID 2 Trial Results and Collaboration
34:28 • 2min
Impact of Delta Wave Enrollment on Trial Results and Global Collaborations
36:58 • 3min